Next-generation medical devices for neurovascular disease


Finalist in the MedTech Innovator Competition


Oxford Endovascular profiles its Origami Engineering research to treat Brain Aneurysms as a finalist in the MedTech Innovator competition

About Us


Oxford Endovascular Ltd is a spin-out from Oxford University, working to prevent brain haemorrhage by curing brain aneurysms, a condition that affects 1 in 50 persons.

OxiFlow™️ is a novel, next generation flow-diverter, that diverts blood flow away from intracranial aneurysms at risk of rupture. It places more accurately and safely than existing devices, reducing the risk of complications. It conforms better to blood vessels making more patients treatable

Our Mission


Invented by a world-renowned physician who pioneered the treatment of aneurysms over the last 30 years and an expert in ‘origami engineering’, it has patents in Europe, US, China & Japan.

The company has raised over $10m to support its development including winning a prestigious Horizon 2020 grant from the European Union following extensive due diligence by medical, industry and investor experts.

Targeting a market over $1 billion, that is growing rapidly, Oxford Endovascular is poised for significant increased value as it addresses unmet clinical needs.

Team of Success


CEO – Mike Karim

Over 30 years of international experience in medical devices including endovascular products. Leadership roles in general management, sales & marketing and mentoring. Success in fund raising, driving business growth in large corporations, SMEs and start ups, developing and bringing new products to market.



Chairman – Chas Taylor

Experienced serial entrepreneur who has founded, led and successfully sold three MedTech companies (Veryan, Novate, MedNova), raising in excess of £100m funding from private, Venture Capital, Venture Debt and Corporate sources. Has mentored multiple businesses delivering value creation through development, regulatory and commercial strategies.


Non-exec Director – Brian Howlett

Long career as a medtech business leader including with endovascular products. Board member of three emerging medtech companies, CEO of Lombard Medical Technologies (2005-2009), General Manager of Boston Scientific in UK (1999-2005)


Clinical Director – James Byrne

Professor of Neuroradiology & Consultant Neuroradiologist with over 30 years of clinical experience treating aneurysm patients. Led over 30 courses training MDs to treat aneurysms and has a track record in prototype development and device testing.


Technology Director – Zhong You

Professor of Engineering Science and an expert in origami structures & minimally invasive medical devices. Gained funding from the Wellcome Trust Centre of Excellence to develop prototype medical devices.

News & Events


 

Senior Quality Engineer

Job DescriptionThe role supports key quality and engineering activities such as risk management activities, process and product audits, Engineering and...
Read More

Regulatory Affairs and Quality Assurance Associate

Job DescriptionThe purpose of the Regulatory Affairs and Quality Assurance Associate is to support the Regulatory and Quality department in...
Read More

R&D Engineer III (Senior R&D Engineer)

Job DescriptionThe Senior R&D Engineer is a key member of an engineering team based in Oxford, developing a novel neurovascular...
Read More

R&D Engineer II

Job DescriptionThe R&D Engineer II is a key member of an engineering team based in Oxford, developing a novel neurovascular...
Read More

R&D Engineer I

Job DescriptionThe R&D Engineer I is a key member of an engineering team based in Oxford, developing a novel neurovascular...
Read More

Research & Development Technician at a Pioneering Medical Device Company spun out of Oxford University

Job Description The R&D Technician will be a key member of an experienced engineering team based in Oxford, developing a...
Read More

Oxford Endovascular – raises £8m to tackle brain aneurysms

London, 20th May 2024: Oxford Endovascular today announces the successful completion of an £8 million Series A+ funding round. The MedTech start-up,...
Read More

Oxford Endovascular selected for Interview at LSI Europe 2022!

LSI Europe in London this Sept was a great event profiling the latest development in MedTech. Mike Karim, CEO, was...
Read More

Oxford Endovascular is honoured to be part of the MedTech Showcase Panel hosted by J&J at the Advamed Conference in Boston to discuss our Origami Engineering technology to treat brain aneurysms

Oxford Endovascular Wins 'Best Medtech Video' at the MedTech Innovator finals in Boston during the Advamed Conference. Thanks to Paul...
Read More

Oxford Endovascular Wins ‘Best Medtech Video’ at the MedTech Innovator finals in Boston, USA, during the Advamed MedTech Conference.

Oxford Endovascular Wins 'Best Medtech Video' at the MedTech Innovator finals in Boston, USA, during the Advamed MedTech Conference.Oxford Endovascular,...
Read More